EN
icon
CN
CN | EN
Board of Directors
Chengbin Wu Ph.D.
Founder
Dr. Chengbin Wu is the founder and Chief Executive Officer of EpimAb Biotherapeutics. Before founding EpimAb, he was Chief Scientific Officer and President of R&D at 3Sbio, a leading China-based biopharmaceutical company focusing on developing therapeutic antibodies to treat various diseases. Previously he was the Senior VP Biologics at Shanghai ChemPartner, where he established comprehensive biologics R&D capabilities.Before that he was a Volwiler Associate Fellow at Abbvie, USA. Dr. Wu has extensive experience in engineering and development of therapeutic monoclonal antibodies. He is also the primary inventor of the FIT-Ig® technology, a new bi-specific antibody platform for developing next generation biologics therapies. Dr. Wu received his Ph.D. degree from the University of Georgia in the US, and postdoctoral training at Harvard Medical School.
Bob Kamen, Ph.D.
Member of Board
Yajun Xu, Ph.D.
Member of Board
Eric Zhao
Member of Board
Min Cui, Ph.D.
Member of Board
Dongfang Li
Member of Board
Cheng Xing
Member of Board
Edward Lu
Member of Board
Sungwon Song
Member of Board